Can Agilent Blame This Miss on the Economy?

You win some, you lose some. This time, Agilent's (NYSE: A  ) losses outweighed the wins.

The maker of chemical, electronic, medical, and communications measurement tools just reported a weak third quarter. Strength in wireless communications, medical diagnostics, and forensics was drowned out by soft orders from industrial and defense customers. In Agilent's opinion, all the bad news came from a slowing economy.

All things considered, Agilent reported 2% sales growth year over year at $1.7 billion and non-GAAP earnings climbed 2.6% to $0.79 per share. Both numbers fell short of analyst targets. Moreover, guidance for the fourth quarter came in far weaker than the current Street view. So it's hardly surprising that shares fell hard overnight, bottoming out nearly 8% below Wednesday's closing prices.

CEO Bill Sullivan took a dim view of Agilent's near-term prospects. Customers in many segments are delaying their expected orders, and there's no guarantee that all these lagging orders will come through. "While we are not seeing outright order cancellations, we're seeing all the classic signs of a slowdown," he said. "Looking ahead, we believe we're entering a slow growth environment."

At the same time, head-on rival Aeroflex (NYSE: ARX  ) beat Wall Street's earnings targets in its own report this morning. Thermo Fisher Scientific (NYSE: TMO  ) and Bruker (Nasdaq: BRKR  ) had no such cushion to fall back on. Both stocks are underperforming the market on Thursday, largely on Agilent's negative end-market comments.

The gap between the Agilent and Aeroflex reports makes me wonder whether demand really is all that weak. Maybe Agilent is simply losing market share to smaller and hungrier rivals. Medical expert Thermo Fisher wouldn't count, given that even Agilent is doing well in that sector. Use your Foolish watchlist to keep an eye on the measurement industry -- ironically, I don't think we have enough data to reach a solid diagnosis yet.

As for Agilent itself, this sudden drop isn't big enough to create a screaming value. Shares are trading at 11.9 times trailing earnings and three times book value right now, which is roughly in line with Agilent's recent history:

 A Price / Book Value Chart

A Price/Book Value data by YCharts.

Thermo Fisher, on the other hand, is an active recommendation from our Inside Value bargain-hunting newsletter. There's still hope for this sector.

And keep in mind that government spending could skyrocket when this year's presidential election is in the books. To see why this event should boost defense and health care businesses across the board -- no matter which party walks off with a win -- you should grab our free report on the topic. Get your copy right now, because this unbeatable deal won't be around forever.

Fool contributor Anders Bylund holds no position in any of the companies mentioned. Check out Anders' holdings and bio, or follow him on Twitter and Google+. Motley Fool newsletter services have recommended buying shares of Thermo Fisher Scientific. The Motley Fool has a disclosure policy.

We Fools may not all hold the same opinion, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1987216, ~/Articles/ArticleHandler.aspx, 10/24/2016 6:20:40 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,223.03 77.32 0.43%
S&P 500 2,151.33 10.17 0.47%
NASD 5,309.83 52.43 1.00%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/24/2016 4:02 PM
A $45.85 Up +0.28 +0.61%
Agilent Technologi… CAPS Rating: ***
ARX.DL $0.00 Down +0.00 +0.00%
Aeroflex Holding CAPS Rating: *
BRKR $21.94 Up +0.48 +2.24%
Bruker CAPS Rating: *****
TMO $153.11 Up +2.45 +1.63%
Thermo Fisher Scie… CAPS Rating: ****